07:00 , Jun 19, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML); leukemia; multiple myeloma (MM) Cyclin D1 (CCND1; BCL1); cyclin D2 (CCND2); cyclin D3 (CCND3) Studies in...
07:00 , May 8, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Multiple myeloma (MM) Cyclin D1 (CCND1); cyclin D2 (CCND2) Studies in cell lines and mice suggest that kinetin riboside could be...